Unraveling a novel therapeutic facet of Etravirine to confront Hepatocellular Carcinoma via disruption of cell cycle

Abstract Hepatocellular Carcinoma (HCC) is a malignancy with high mortality rates and limited treatment options. This study aimed to unearth the repurposable potential of FDA-approved drugs against specific genetic targets governing the HCC pathological pathways. The transcriptomics microarray datas...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Gouri Nair, G. R. Saraswathy, Jesil Mathew Aranjani, Rafwana Ibrahim
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2025-02-01
Edice:	Scientific Reports
Témata:	Hepatocellular Carcinoma Drug repurposing CCNA2 CDK1 CDK2 Etravirine
On-line přístup:	https://doi.org/10.1038/s41598-025-87676-3
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!